Willingness to pay for a quality-adjusted life year among advanced non-small cell lung cancer patients in Viet Nam, 2018
Ha, Thuy Van PhDa; Hoang, Minh Van MD, PhDb,∗; Vu, Mai Quynh MScb; Hoang, Ngoc-Anh Thi BPhb; Khuong, Long Quynh MDb; Vu, Anh Nu MSca; Pham, Phuong Cam MD, PhDc; Vu, Chinh Van MD, MScd; Duong, Lieu Huy MD, PhDd
Section Editor(s): Wane., Daryle
aViet Nam Department of Health Insurance, Ministry of Health
bHanoi University of Public Health
cBach Mai Hospital
dViet Nam Health Economics Association, Hanoi, Viet Nam.
To examine the willingness to pay (WTP) for a quality-adjusted life year (QALY) gained among advanced non-small cell lung cancer (NSCLC) patients in Viet Nam and to analyze the factors affecting an individual's WTP. A cross-sectional, contingent valuation study was conducted among 400 NSCLC patients across 6 national hospitals in Viet Nam. Self-reported information was recorded from patients regarding their socio-demographic status, EQ-5D (EuroQol-5 dimensions) utility, EQ-5D vas, and WTP for 1 QALY gained. To explore the factors related to the WTP, Gamma Generalized Linear Model and multiple logistic regression tools were applied to analyze data. The overall mean and median of WTP/QALY among the NSCLC patients were USD $11,301 and USD $8002, respectively. Strong association was recorded between WTP/QALY amount and the patient's education, economic status, comorbidity status, and health utility. Government and policymakers should consider providing financial supports to disadvantaged groups to improve their access to life saving cancer treatment.